Evidence map›Paper›PMID 23436654›Full record

ArticleThe Journal of biological chemistry2013

Specific interaction of the transcription elongation regulator TCERG1 with RNA polymerase II requires simultaneous phosphorylation at Ser2, Ser5, and Ser7 within the carboxyl-terminal domain repeat.

Jiangxin Liu, Shilong Fan, Chul-Jin Lee, Arno L Greenleaf, Pei Zhou

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Milestones in transcription and chromatin published in theThe Journal of biological chemistry · 2019
    Review
  10. Article
  11. Article
  12. Article
  13. O-GlcNAc and the epigenetic regulation of gene expression.The Journal of biological chemistry · 2014
    Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Jiangxin LiuDepartment of Biochemistry, Duke University Medical Center, Durham, North Carolina 27710, USA.
Shilong Fan
Chul-Jin Lee
Arno L Greenleaf
Pei Zhou
Duke University · USDuke University Hospital · USMRC Laboratory of Molecular Biology · GB

Funding

TRANSCRIPTASE KINASES FROM YEAST AND DROSOPHILAR01GM040505 · NIGMS · DUKE UNIVERSITY · PI GREENLEAF, ARNO L. · 1988 to 2014
$5.1M
Structural, Biochemical and Functional Studies of RNAPII CTD Interacting ProteinsR01GM079376 · NIGMS · DUKE UNIVERSITY · PI ZHOU, PEI · 2008 to 2011
$1.2M
NIGMS NIH HHS R01 GM040505NIGMS NIH HHS R01 GM079376
6 · The paper itself

Abstract

The human transcription elongation regulator TCERG1 physically couples transcription elongation and splicing events by interacting with splicing factors through its N-terminal WW domains and the hyperphosphorylated C-terminal domain (CTD) of RNA polymerase II through its C-terminal FF domains. Here, we report biochemical and structural characterization of the C-terminal three FF domains (FF4-6) of TCERG1, revealing a rigid integral domain structure of the tandem FF repeat that interacts with the hyperphosphorylated CTD (PCTD). Although FF4 and FF5 adopt a classical FF domain fold containing three orthogonally packed α helices and a 310 helix, FF6 contains an additional insertion helix between α1 and α2. The formation of the integral tandem FF4-6 repeat is achieved by merging the last helix of the preceding FF domain and the first helix of the following FF domain and by direct interactions between neighboring FF domains. Using peptide column binding assays and NMR titrations, we show that binding of the FF4-6 tandem repeat to the PCTD requires simultaneous phosphorylation at Ser(2), Ser(5), and Ser(7) positions within two consecutive Y(1)S(2)P(3)T(4)S(5)P(6)S(7) heptad repeats. Such a sequence-specific PCTD recognition is achieved through CTD-docking sites on FF4 and FF5 of TCERG1 but not FF6. Our study presents the first example of a nuclear factor requiring all three phospho-Ser marks within the heptad repeat of the CTD for high affinity binding and provides a molecular interpretation for the biochemical connection between the Ser(7) phosphorylation enrichment in the CTD of the transcribing RNA polymerase II over introns and co-transcriptional splicing events.

Indexed as

HumansNuclear Magnetic Resonance, BiomolecularPhosphorylationProtein BindingProtein Structure, SecondaryProtein Structure, TertiaryRepetitive Sequences, Amino AcidRNA Polymerase IISerineTranscriptional Elongation FactorsRNA Polymerase IISerineTCERG1 protein, humanTranscriptional Elongation Factors

Identifiers

PMID23436654
PMCPMC3624469
OpenAlexW2079542882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.